| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.681 | 0.008 | 0.681 | Vasodilator, peripheral | 0.388 0.059 DBMET00536 0.627 0.013 DB00627 | ||
| 0.662 | 0.011 | 0.696 | Cholesterol antagonist | 0.444 0.042 DBMET00536 0.696 0.008 DB00627 | DB00627 | |
| 0.618 | 0.005 | 0.618 | Calcium channel L-type activator | 0.522 0.02 DBMET00536 0.388 0.089 DB00627 | ||
| 0.56 | 0.017 | 0.724 | 5 Hydroxytryptamine release inhibitor | 0.55 0.019 DBMET00536 0.724 0.004 DB00627 | DB00627 | |
| 0.539 | 0.009 | 0.539 | Vasodilator | 0.392 0.025 DB00627 | ||
| 0.537 | 0.017 | 0.554 | GABA C receptor rho-3 antagonist | 0.554 0.014 DBMET00536 0.538 0.017 DB00627 | DBMET00536 | |
| 0.535 | 0.02 | 0.621 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.513 0.028 DBMET00536 0.621 0.005 DB00627 | DB00627 | |
| 0.511 | 0.004 | 0.511 | Calcium channel activator | 0.419 0.018 DBMET00536 0.391 0.028 DB00627 | ||
| 0.501 | 0.015 | 0.501 | Vasodilator, coronary | 0.335 0.063 DBMET00536 0.395 0.037 DB00627 | ||
| 0.508 | 0.026 | 0.702 | Histamine release inhibitor | 0.465 0.043 DBMET00536 0.702 0.005 DB00627 | DB00627 | |
| 0.449 | 0.014 | 0.562 | Peroxidase inhibitor | 0.562 0.005 DBMET00536 0.526 0.008 DB00627 | DBMET00536 | |
| 0.483 | 0.067 | 0.555 | Caspase 9 stimulant | 0.555 0.044 DBMET00536 0.413 0.103 DB00627 | DBMET00536 | |
| 0.418 | 0.007 | 0.455 | NOS3 expression enhancer | 0.455 0.006 DB00627 | DB00627 | |
| 0.377 | 0.004 | 0.377 | GABA C receptor rho-2 antagonist | 0.293 0.006 DBMET00536 0.253 0.011 DB00627 | ||
| 0.376 | 0.031 | 0.634 | Superoxide dismutase inhibitor | 0.491 0.014 DBMET00536 0.634 0.005 DB00627 | DB00627 | |
| 0.365 | 0.023 | 0.365 | Platelet aggregation inhibitor | 0.211 0.074 DB00627 | ||
| 0.343 | 0.005 | 0.353 | Nitric-oxide synthase stimulant | 0.308 0.01 DBMET00536 0.353 0.005 DB00627 | DB00627 | |
| 0.366 | 0.044 | 0.366 | Aryl hydrocarbon receptor agonist | 0.188 0.109 DBMET00536 0.252 0.078 DB00627 | ||
| 0.342 | 0.028 | 0.347 | Cyclic AMP phosphodiesterase inhibitor | 0.261 0.058 DBMET00536 0.347 0.026 DB00627 | DB00627 | |
| 0.318 | 0.008 | 0.344 | 3C-like protease (Human coronavirus) inhibitor | 0.206 0.048 DBMET00536 0.344 0.005 DB00627 | DB00627 | |
| 0.327 | 0.028 | 0.357 | Anesthetic general | 0.357 0.023 DBMET00536 0.263 0.045 DB00627 | DBMET00536 | |
| 0.313 | 0.017 | 0.313 | Cytidine deaminase inhibitor | 0.17 0.062 DBMET00536 0.25 0.029 DB00627 | ||
| 0.31 | 0.03 | 0.361 | RNA-directed DNA polymerase inhibitor | 0.361 0.023 DBMET00536 0.306 0.03 DB00627 | DBMET00536 | |
| 0.386 | 0.114 | 0.386 | MAP kinase 1 inhibitor | 0.254 0.229 DB00627 | ||
| 0.34 | 0.068 | 0.43 | Antithrombotic | 0.278 0.105 DBMET00536 0.43 0.042 DB00627 | DB00627 | |
| 0.325 | 0.055 | 0.325 | Hypoxia-inducible factor 1 alpha inhibitor | 0.214 0.135 DBMET00536 0.285 0.073 DB00627 | ||
| 0.266 | 0.004 | 0.266 | CYP2A6 inhibitor | 0.102 0.035 DBMET00536 0.228 0.005 DB00627 | ||
| 0.318 | 0.063 | 0.318 | Spasmolytic | 0.179 0.137 DBMET00536 0.304 0.068 DB00627 | ||
| 0.298 | 0.046 | 0.45 | 5 Hydroxytryptamine uptake stimulant | 0.45 0.007 DBMET00536 0.404 0.013 DB00627 | DBMET00536 | |
| 0.273 | 0.024 | 0.273 | Tumour necrosis factor antagonist | 0.159 0.089 DBMET00536 0.181 0.067 DB00627 | ||
| 0.288 | 0.039 | 0.288 | 5 Hydroxytryptamine 1E antagonist | 0.244 0.081 DBMET00536 0.174 0.162 DB00627 | ||
| 0.248 | 0.008 | 0.779 | Porphobilinogen synthase inhibitor | 0.334 0.005 DBMET00536 0.779 0.002 DB00627 | DB00627 | |
| 0.297 | 0.06 | 0.338 | Insulysin inhibitor | 0.321 0.047 DBMET00536 0.338 0.039 DB00627 | DB00627 | |
| 0.24 | 0.005 | 0.255 | GABA C receptor rho-1 antagonist | 0.255 0.004 DBMET00536 0.254 0.004 DB00627 | DBMET00536 | |
| 0.261 | 0.026 | 0.267 | Interferon gamma antagonist | 0.244 0.029 DBMET00536 0.267 0.025 DB00627 | DB00627 | |
| 0.228 | 0.003 | 0.228 | Potassium channel intermediate-conductance Ca-activated blocker | 0.074 0.023 DBMET00536 0.095 0.01 DB00627 | ||
| 0.228 | 0.004 | 0.228 | Acetylcholine release stimulant | 0.138 0.025 DBMET00536 0.174 0.007 DB00627 | ||
| 0.312 | 0.089 | 0.312 | Transcription factor NF kappa B inhibitor | 0.262 0.119 DBMET00536 0.295 0.097 DB00627 | ||
| 0.229 | 0.01 | 0.335 | Histidine decarboxylase inhibitor | 0.295 0.006 DBMET00536 0.335 0.005 DB00627 | DB00627 | |
| 0.25 | 0.032 | 0.263 | MAP kinase kinase 3 inhibitor | 0.263 0.021 DB00627 | DB00627 | |
| 0.223 | 0.007 | 0.358 | Keratolytic | 0.164 0.012 DBMET00536 0.358 0.003 DB00627 | DB00627 | |
| 0.234 | 0.026 | 0.7 | Alpha-N-acetylglucosaminidase inhibitor | 0.7 0.003 DBMET00536 0.627 0.004 DB00627 | DBMET00536 | |
| 0.295 | 0.089 | 0.312 | Apoptosis antagonist | 0.312 0.078 DB00627 | DB00627 | |
| 0.224 | 0.019 | 0.242 | Mannose-6-phosphate isomerase inhibitor | 0.242 0.014 DBMET00536 0.235 0.016 DB00627 | DBMET00536 | |
| 0.224 | 0.024 | 0.224 | Interleukin 1 antagonist | 0.166 0.048 DB00627 | ||
| 0.222 | 0.022 | 0.277 | Cholesterol synthesis inhibitor | 0.184 0.031 DBMET00536 0.277 0.014 DB00627 | DB00627 | |
| 0.203 | 0.01 | 0.203 | TRPA1 agonist | 0.143 0.036 DBMET00536 0.161 0.024 DB00627 | ||
| 0.204 | 0.012 | 0.295 | GABA C receptor antagonist | 0.295 0.004 DBMET00536 0.24 0.007 DB00627 | DBMET00536 | |
| 0.264 | 0.073 | 0.264 | DNA damaging | 0.198 0.117 DBMET00536 0.213 0.105 DB00627 | ||
| 0.21 | 0.024 | 0.21 | Platelet activating factor antagonist | |||
| 0.193 | 0.008 | 0.209 | DOPA decarboxylase inhibitor | 0.209 0.005 DBMET00536 0.2 0.007 DB00627 | DBMET00536 | |
| 0.192 | 0.007 | 0.911 | Alcohol oxidase inhibitor | 0.911 0.002 DBMET00536 0.851 0.002 DB00627 | DBMET00536 | |
| 0.203 | 0.019 | 0.203 | Interleukin 1b antagonist | 0.146 0.043 DB00627 | ||
| 0.213 | 0.029 | 0.213 | Alkaline phosphatase inhibitor | 0.131 0.075 DBMET00536 0.208 0.03 DB00627 | ||
| 0.203 | 0.02 | 0.602 | GABA C receptor agonist | 0.576 0.003 DBMET00536 0.602 0.003 DB00627 | DB00627 | |
| 0.255 | 0.073 | 0.293 | Gastrin inhibitor | 0.293 0.038 DBMET00536 0.293 0.038 DB00627 | DB00627 | |
| 0.186 | 0.005 | 0.202 | Histone deacetylase stimulant | 0.202 0.005 DB00627 | DB00627 | |
| 0.186 | 0.005 | 0.202 | Histone deacetylase SIRT1 stimulant | 0.202 0.005 DB00627 | DB00627 | |
| 0.248 | 0.068 | 0.349 | DNA synthesis inhibitor | 0.34 0.032 DBMET00536 0.349 0.03 DB00627 | DB00627 | |
| 0.204 | 0.024 | 0.308 | Cystathionine beta-synthase inhibitor | 0.296 0.01 DBMET00536 0.308 0.009 DB00627 | DB00627 | |
| 0.188 | 0.01 | 0.347 | Electrolyte absorption antagonist | 0.202 0.008 DBMET00536 0.347 0.003 DB00627 | DB00627 | |
| 0.186 | 0.009 | 0.186 | Heat shock protein 70 antagonist | 0.171 0.017 DBMET00536 0.181 0.011 DB00627 | ||
| 0.177 | 0.004 | 0.177 | Granulocyte macrophage colony stimulating factor agonist | 0.16 0.004 DBMET00536 0.134 0.009 DB00627 | ||
| 0.227 | 0.054 | 0.241 | Non-steroidal antiinflammatory agent | 0.181 0.086 DBMET00536 0.241 0.047 DB00627 | DB00627 | |
| 0.204 | 0.033 | 0.271 | Hexokinase inhibitor | 0.204 0.033 DBMET00536 0.271 0.014 DB00627 | DB00627 | |
| 0.211 | 0.043 | 0.211 | Heat shock protein 90 alpha antagonist | 0.205 0.046 DB00627 | ||
| 0.221 | 0.057 | 0.313 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.313 0.02 DBMET00536 0.256 0.04 DB00627 | DBMET00536 | |
| 0.219 | 0.056 | 0.257 | Insulin sensitizer | 0.209 0.065 DBMET00536 0.257 0.03 DB00627 | DB00627 | |
| 0.213 | 0.052 | 0.221 | Histone acetyltransferase inhibitor | 0.179 0.102 DBMET00536 0.221 0.043 DB00627 | DB00627 | |
| 0.179 | 0.018 | 0.191 | Photosensitizer | 0.191 0.015 DBMET00536 0.142 0.036 DB00627 | DBMET00536 | |
| 0.195 | 0.038 | 0.229 | Arachidonic acid antagonist | 0.229 0.012 DBMET00536 0.204 0.029 DB00627 | DBMET00536 | |
| 0.16 | 0.006 | 0.16 | Nicotinic alpha4beta2 receptor antagonist | 0.081 0.049 DBMET00536 0.113 0.022 DB00627 | ||
| 0.294 | 0.141 | 0.37 | MAP kinase kinase 6 inhibitor | 0.37 0.078 DB00627 | DB00627 | |
| 0.173 | 0.021 | 0.198 | Protein kinase C gamma inhibitor | 0.117 0.055 DBMET00536 0.198 0.014 DB00627 | DB00627 | |
| 0.163 | 0.012 | 0.171 | Macrophage migration inhibitory factor inhibitor | 0.103 0.033 DBMET00536 0.171 0.011 DB00627 | DB00627 | |
| 0.155 | 0.004 | 0.259 | Glutamate (mGluR group III) antagonist | 0.063 0.012 DBMET00536 0.259 0.003 DB00627 | DB00627 | |
| 0.197 | 0.051 | 0.394 | Succinate dehydrogenase inhibitor | 0.394 0.004 DBMET00536 0.313 0.009 DB00627 | DBMET00536 | |
| 0.165 | 0.019 | 0.165 | Phosphodiesterase IV inhibitor | 0.091 0.053 DB00627 | ||
| 0.178 | 0.034 | 0.388 | Aldehyde dehydrogenase inhibitor | 0.388 0.006 DBMET00536 0.307 0.011 DB00627 | DBMET00536 | |
| 0.165 | 0.022 | 0.305 | Adenylate kinase inhibitor | 0.305 0.007 DBMET00536 0.257 0.009 DB00627 | DBMET00536 | |
| 0.184 | 0.042 | 0.184 | Cytokine production inhibitor | 0.134 0.076 DB00627 | ||
| 0.145 | 0.004 | 0.441 | Aconitate hydratase inhibitor | 0.199 0.003 DBMET00536 0.441 0.002 DB00627 | DB00627 | |
| 0.159 | 0.02 | 0.159 | Calcium antagonist | 0.121 0.035 DBMET00536 | ||
| 0.157 | 0.019 | 0.157 | Acetylcholine nicotinic antagonist | 0.105 0.036 DB00627 | ||
| 0.141 | 0.004 | 0.286 | Glutamate (mGluR4) antagonist | 0.059 0.014 DBMET00536 0.286 0.003 DB00627 | DB00627 | |
| 0.169 | 0.034 | 0.178 | Antibacterial (Helicobacter pylori) | 0.119 0.083 DBMET00536 0.178 0.029 DB00627 | DB00627 | |
| 0.173 | 0.039 | 0.218 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.218 0.012 DB00627 | DB00627 | |
| 0.292 | 0.159 | 0.292 | Transcription factor inhibitor | |||
| 0.159 | 0.028 | 0.212 | Carbonic anhydrase XV inhibitor | 0.208 0.017 DBMET00536 0.212 0.017 DB00627 | DB00627 | |
| 0.144 | 0.013 | 0.165 | Ornithine decarboxylase inhibitor | 0.121 0.025 DBMET00536 0.165 0.008 DB00627 | DB00627 | |
| 0.136 | 0.005 | 0.136 | Oleamide hydrolase inhibitor | 0.091 0.01 DB00627 | ||
| 0.227 | 0.097 | 0.316 | Interleukin agonist | 0.316 0.041 DBMET00536 0.272 0.064 DB00627 | DBMET00536 | |
| 0.154 | 0.025 | 0.154 | Gastric antisecretory | 0.086 0.084 DBMET00536 0.136 0.033 DB00627 | ||
| 0.15 | 0.021 | 0.15 | Toll-Like receptor 4 antagonist | 0.103 0.065 DBMET00536 | ||
| 0.141 | 0.013 | 0.141 | Neuronal nicotinic receptor antagonist | 0.094 0.027 DB00627 | ||
| 0.139 | 0.013 | 0.164 | Glutamate release inhibitor | 0.164 0.007 DBMET00536 0.104 0.037 DB00627 | DBMET00536 | |
| 0.156 | 0.03 | 0.197 | Ca2+-transporting ATPase inhibitor | 0.197 0.004 DBMET00536 0.187 0.005 DB00627 | DBMET00536 | |
| 0.203 | 0.078 | 0.203 | Psychostimulant | 0.192 0.084 DBMET00536 0.165 0.104 DB00627 | ||
| 0.169 | 0.045 | 0.169 | Calcium channel blocker | |||
| 0.134 | 0.01 | 0.194 | DNA gyrase inhibitor | 0.194 0.005 DB00627 | DB00627 | |
| 0.158 | 0.035 | 0.158 | Beta amyloid protein antagonist | 0.127 0.06 DBMET00536 0.143 0.045 DB00627 | ||
| 0.209 | 0.087 | 0.266 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.266 0.061 DB00627 | DB00627 | |
| 0.25 | 0.128 | 0.323 | Sodium/bile acid cotransporter inhibitor | 0.315 0.066 DBMET00536 0.323 0.059 DB00627 | DB00627 | |
| 0.165 | 0.043 | 0.194 | Toll-Like receptor 2 antagonist | 0.194 0.026 DBMET00536 0.114 0.085 DB00627 | DBMET00536 | |
| 0.167 | 0.046 | 0.168 | MAP kinase 3 inhibitor | 0.148 0.07 DBMET00536 0.168 0.045 DB00627 | DB00627 | |
| 0.218 | 0.097 | 0.367 | Hypoglycemic | 0.367 0.034 DB00627 | DB00627 | |
| 0.195 | 0.075 | 0.275 | I kappa B kinase epsilon inhibitor | 0.204 0.068 DBMET00536 0.275 0.025 DB00627 | DB00627 | |
| 0.124 | 0.005 | 0.124 | Nicotinic alpha3beta2 receptor antagonist | 0.062 0.024 DBMET00536 0.072 0.016 DB00627 | ||
| 0.236 | 0.12 | 0.236 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.159 | 0.043 | 0.169 | Interleukin 4 antagonist | 0.169 0.035 DB00627 | DB00627 | |
| 0.186 | 0.07 | 0.186 | LIM domain kinase 1 inhibitor | 0.144 0.104 DB00627 | ||
| 0.152 | 0.037 | 0.152 | Death-associated protein kinase 1 inhibitor | 0.151 0.038 DB00627 | ||
| 0.136 | 0.022 | 0.223 | ABCA1 expression enhancer | 0.223 0.008 DB00627 | DB00627 | |
| 0.212 | 0.099 | 0.898 | Aldehyde oxidase inhibitor | 0.898 0.003 DBMET00536 0.563 0.024 DB00627 | DBMET00536 | |
| 0.134 | 0.021 | 0.147 | Histamine N-methyltransferase inhibitor | 0.116 0.033 DBMET00536 0.147 0.015 DB00627 | DB00627 | |
| 0.149 | 0.037 | 0.149 | GABA receptor agonist | 0.099 0.078 DB00627 | ||
| 0.264 | 0.154 | 0.264 | 15-Lipoxygenase inhibitor | |||
| 0.126 | 0.019 | 0.126 | Bromodomain-containing protein 2 inhibitor | 0.1 0.04 DBMET00536 0.096 0.045 DB00627 | ||
| 0.111 | 0.006 | 0.13 | Glutamate (mGluR7) antagonist | 0.124 0.004 DBMET00536 0.13 0.004 DB00627 | DB00627 | |
| 0.162 | 0.057 | 0.204 | CF transmembrane conductance regulator agonist | 0.204 0.019 DBMET00536 0.145 0.085 DB00627 | DBMET00536 | |
| 0.186 | 0.082 | 0.186 | Focal adhesion kinase 2 inhibitor | 0.157 0.119 DBMET00536 0.161 0.114 DB00627 | ||
| 0.142 | 0.039 | 0.283 | Chelator | 0.283 0.012 DB00627 | DB00627 | |
| 0.252 | 0.148 | 0.252 | Calpain 2 inhibitor | 0.196 0.191 DBMET00536 0.23 0.164 DB00627 | ||
| 0.127 | 0.024 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 DBMET00536 0.14 0.015 DB00627 | DB00627 | |
| 0.117 | 0.016 | 0.117 | Caspase 7 inhibitor | 0.092 0.038 DBMET00536 0.085 0.05 DB00627 | ||
| 0.15 | 0.049 | 0.173 | Cyclooxygenase 3 inhibitor | 0.173 0.032 DBMET00536 0.147 0.051 DB00627 | DBMET00536 | |
| 0.199 | 0.099 | 0.256 | Dyrk kinase inhibitor | 0.256 0.069 DB00627 | DB00627 | |
| 0.105 | 0.006 | 0.179 | Thromboxane synthase inhibitor | 0.054 0.038 DBMET00536 0.179 0.004 DB00627 | DB00627 | |
| 0.156 | 0.057 | 0.156 | Neuropeptide Y1 antagonist | 0.134 0.092 DBMET00536 | ||
| 0.212 | 0.115 | 0.431 | Tyrosine 3 hydroxylase inhibitor | 0.431 0.005 DBMET00536 0.261 0.058 DB00627 | DBMET00536 | |
| 0.272 | 0.175 | 0.272 | Alpha-glucosidase inhibitor | |||
| 0.11 | 0.013 | 0.213 | Xanthine dehydrogenase inhibitor | 0.128 0.01 DBMET00536 0.213 0.004 DB00627 | DB00627 | |
| 0.1 | 0.003 | 0.115 | Nerve growth factor antagonist | 0.06 0.009 DBMET00536 0.115 0.002 DB00627 | DB00627 | |
| 0.215 | 0.118 | 0.238 | Transcription factor STAT inhibitor | 0.199 0.14 DBMET00536 0.238 0.095 DB00627 | DB00627 | |
| 0.124 | 0.028 | 0.158 | Carbonic anhydrase XIII inhibitor | 0.129 0.027 DBMET00536 0.158 0.02 DB00627 | DB00627 | |
| 0.164 | 0.069 | 0.164 | Cyclin-dependent kinase 3 inhibitor | 0.146 0.106 DB00627 | ||
| 0.197 | 0.102 | 0.206 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.203 0.098 DBMET00536 0.206 0.097 DB00627 | DB00627 | |
| 0.137 | 0.043 | 0.408 | Ferrochelatase inhibitor | 0.408 0.004 DBMET00536 0.401 0.004 DB00627 | DBMET00536 | |
| 0.185 | 0.092 | 0.256 | Neurotrophic factor enhancer | 0.256 0.035 DBMET00536 0.24 0.044 DB00627 | DBMET00536 | |
| 0.148 | 0.055 | 0.164 | NADPH oxidase inhibitor | 0.135 0.067 DBMET00536 0.164 0.047 DB00627 | DB00627 | |
| 0.152 | 0.06 | 0.207 | Adenylate cyclase stimulant | 0.207 0.011 DBMET00536 0.17 0.035 DB00627 | DBMET00536 | |
| 0.117 | 0.026 | 0.117 | GABA A receptor agonist | 0.075 0.073 DB00627 | ||
| 0.094 | 0.004 | 0.099 | Pregnane X receptor antagonist | 0.086 0.005 DBMET00536 0.099 0.004 DB00627 | DB00627 | |
| 0.148 | 0.057 | 0.148 | Toll-Like receptor antagonist | |||
| 0.156 | 0.068 | 0.156 | Heat shock protein 90 antagonist | 0.138 0.087 DB00627 | ||
| 0.102 | 0.016 | 0.117 | Glutamate (mGluR1) antagonist | 0.117 0.012 DB00627 | DB00627 | |
| 0.115 | 0.03 | 0.121 | Phosphodiesterase 6D inhibitor | 0.104 0.045 DBMET00536 0.121 0.024 DB00627 | DB00627 | |
| 0.164 | 0.079 | 0.211 | ATPase inhibitor | 0.211 0.029 DBMET00536 0.143 0.114 DB00627 | DBMET00536 | |
| 0.208 | 0.123 | 0.213 | Transcription factor STAT3 inhibitor | 0.21 0.121 DBMET00536 0.213 0.118 DB00627 | DB00627 | |
| 0.125 | 0.04 | 0.347 | UDP-glucose 4-epimerase inhibitor | 0.347 0.008 DBMET00536 0.328 0.009 DB00627 | DBMET00536 | |
| 0.176 | 0.091 | 0.245 | Death-associated protein kinase 3 inhibitor | 0.245 0.054 DB00627 | DB00627 | |
| 0.127 | 0.044 | 0.22 | Xanthine oxidase inhibitor | 0.22 0.016 DBMET00536 0.202 0.019 DB00627 | DBMET00536 | |
| 0.105 | 0.022 | 0.105 | Amidase inhibitor | 0.102 0.023 DB00627 | ||
| 0.179 | 0.096 | 0.193 | MAP kinase kinase 2 inhibitor | 0.193 0.086 DBMET00536 0.184 0.093 DB00627 | DBMET00536 | |
| 0.094 | 0.012 | 0.101 | Exportin-1 inhibitor | 0.101 0.009 DBMET00536 0.092 0.013 DB00627 | DBMET00536 | |
| 0.144 | 0.062 | 0.144 | Nav1.6 sodium channel blocker | 0.143 0.062 DBMET00536 | ||
| 0.133 | 0.051 | 0.155 | Sphingosine 1-phosphate receptor 4 antagonist | 0.155 0.029 DBMET00536 0.138 0.045 DB00627 | DBMET00536 | |
| 0.145 | 0.064 | 0.189 | Neurotrophic factor | 0.189 0.033 DB00627 | DB00627 | |
| 0.149 | 0.068 | 0.168 | Glycogen synthase kinase-3 alpha inhibitor | 0.168 0.054 DB00627 | DB00627 | |
| 0.093 | 0.014 | 0.093 | Nicotinic receptor alpha7 subunit antagonist | 0.063 0.026 DB00627 | ||
| 0.155 | 0.076 | 0.204 | Melanin inhibitor | 0.204 0.039 DBMET00536 0.146 0.087 DB00627 | DBMET00536 | |
| 0.169 | 0.091 | 0.169 | P-glycoprotein inhibitor | |||
| 0.174 | 0.097 | 0.216 | Pyruvate kinase inhibitor | 0.191 0.086 DBMET00536 0.216 0.073 DB00627 | DB00627 | |
| 0.101 | 0.024 | 0.101 | Calcium channel L-type blocker | |||
| 0.145 | 0.07 | 0.251 | Cell wall synthesis inhibitor | 0.198 0.031 DBMET00536 0.251 0.016 DB00627 | DB00627 | |
| 0.113 | 0.038 | 0.138 | Glutamate (mGluR7) agonist | 0.138 0.017 DBMET00536 0.092 0.077 DB00627 | DBMET00536 | |
| 0.127 | 0.053 | 0.176 | Microtubule formation inhibitor | 0.176 0.027 DBMET00536 0.11 0.074 DB00627 | DBMET00536 | |
| 0.106 | 0.032 | 0.12 | Glutamate (mGluR) antagonist | 0.12 0.026 DB00627 | DB00627 | |
| 0.089 | 0.016 | 0.131 | Glutamate (mGluR6) antagonist | 0.131 0.004 DBMET00536 0.109 0.008 DB00627 | DBMET00536 | |
| 0.119 | 0.047 | 0.119 | Beta glucuronidase inhibitor | 0.119 0.047 DBMET00536 0.115 0.051 DB00627 | ||
| 0.08 | 0.008 | 0.08 | Glutamate (mGluR1a) antagonist | 0.057 0.016 DB00627 | ||
| 0.113 | 0.042 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.112 0.043 DBMET00536 0.106 0.05 DB00627 | ||
| 0.113 | 0.042 | 0.133 | Protein kinase C delta inhibitor | 0.133 0.029 DB00627 | DB00627 | |
| 0.099 | 0.028 | 0.14 | GABA aminotransferase inhibitor | 0.14 0.01 DBMET00536 0.122 0.015 DB00627 | DBMET00536 | |
| 0.108 | 0.037 | 0.316 | NADH dehydrogenase inhibitor | 0.316 0.006 DBMET00536 0.229 0.009 DB00627 | DBMET00536 | |
| 0.145 | 0.074 | 0.212 | Hemostatic | 0.125 0.104 DBMET00536 0.212 0.028 DB00627 | DB00627 | |
| 0.179 | 0.109 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.232 0.026 DBMET00536 0.177 0.115 DB00627 | DBMET00536 | |
| 0.109 | 0.039 | 0.109 | Thioredoxin inhibitor | 0.092 0.058 DB00627 | ||
| 0.091 | 0.021 | 0.289 | Biliverdin reductase inhibitor | 0.227 0.005 DBMET00536 0.289 0.003 DB00627 | DB00627 | |
| 0.074 | 0.006 | 0.129 | DNA gyrase subunit B inhibitor | 0.129 0.004 DB00627 | DB00627 | |
| 0.092 | 0.025 | 0.092 | Acetylcholine M5 receptor agonist | 0.09 0.026 DBMET00536 | ||
| 0.085 | 0.018 | 0.177 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.177 0.007 DBMET00536 0.144 0.009 DB00627 | DBMET00536 | |
| 0.117 | 0.05 | 0.148 | Mediator release inhibitor | 0.148 0.029 DB00627 | DB00627 | |
| 0.193 | 0.127 | 0.61 | 5 Hydroxytryptamine release stimulant | 0.61 0.014 DBMET00536 0.234 0.097 DB00627 | DBMET00536 | |
| 0.072 | 0.008 | 0.214 | Nicotinic acid receptor agonist | 0.043 0.018 DBMET00536 0.214 0.003 DB00627 | DB00627 | |
| 0.075 | 0.012 | 0.089 | Ryanodine receptor antagonist | 0.089 0.005 DBMET00536 0.081 0.008 DB00627 | DBMET00536 | |
| 0.092 | 0.03 | 0.092 | Glutamate (mGluR group I) antagonist | 0.081 0.037 DB00627 | ||
| 0.154 | 0.092 | 0.204 | Neurotensin receptor agonist | 0.204 0.033 DBMET00536 0.172 0.059 DB00627 | DBMET00536 | |
| 0.185 | 0.123 | 0.185 | Tumour necrosis factor alpha release inhibitor | |||
| 0.091 | 0.03 | 0.325 | Phenylalanine 4-hydroxylase inhibitor | 0.194 0.007 DBMET00536 0.325 0.004 DB00627 | DB00627 | |
| 0.099 | 0.039 | 0.099 | Transcription factor NF kappa B stimulant | |||
| 0.089 | 0.029 | 0.089 | Phosphodiesterase VI inhibitor | 0.072 0.056 DBMET00536 0.073 0.055 DB00627 | ||
| 0.138 | 0.079 | 0.157 | Pregnane X receptor agonist | 0.157 0.041 DBMET00536 0.133 0.092 DB00627 | DBMET00536 | |
| 0.069 | 0.01 | 0.119 | Urate transporter 1 inhibitor | 0.044 0.022 DBMET00536 0.119 0.004 DB00627 | DB00627 | |
| 0.084 | 0.025 | 0.097 | Protein kinase C beta inhibitor | 0.072 0.043 DBMET00536 0.097 0.015 DB00627 | DB00627 | |
| 0.104 | 0.045 | 0.104 | Toll-Like receptor 3 antagonist | |||
| 0.105 | 0.046 | 0.105 | Interleukin 12 antagonist | |||
| 0.227 | 0.169 | 0.227 | Beta lactamase inhibitor | |||
| 0.085 | 0.028 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.103 0.012 DBMET00536 0.097 0.016 DB00627 | DBMET00536 | |
| 0.082 | 0.025 | 0.082 | 5 Hydroxytryptamine 3 agonist | 0.073 0.033 DBMET00536 0.057 0.053 DB00627 | ||
| 0.084 | 0.027 | 0.084 | Potassium channel (Tandem pore domain) blocker | 0.08 0.034 DBMET00536 0.07 0.063 DB00627 | ||
| 0.065 | 0.009 | 0.075 | Alpha 1d adrenoreceptor agonist | 0.075 0.006 DBMET00536 0.046 0.019 DB00627 | DBMET00536 | |
| 0.204 | 0.148 | 0.219 | 12-Lipoxygenase inhibitor | 0.219 0.132 DBMET00536 0.203 0.149 DB00627 | DBMET00536 | |
| 0.082 | 0.026 | 0.082 | Potassium channel (ATP-sensitive) blocker | 0.066 0.047 DBMET00536 0.069 0.043 DB00627 | ||
| 0.087 | 0.032 | 0.087 | Phosphodiesterase 4B inhibitor | 0.062 0.053 DB00627 | ||
| 0.101 | 0.046 | 0.331 | Triose-phosphate isomerase inhibitor | 0.331 0.004 DBMET00536 0.295 0.005 DB00627 | DBMET00536 | |
| 0.11 | 0.055 | 0.237 | Protein kinase (CK2) inhibitor | 0.237 0.013 DB00627 | DB00627 | |
| 0.214 | 0.16 | 0.214 | Thioredoxin glutathione reductase inhibitor | |||
| 0.064 | 0.01 | 0.064 | Benzodiazepine antagonist | 0.045 0.04 DB00627 | ||
| 0.118 | 0.064 | 0.133 | Caspase 3 inhibitor | 0.126 0.052 DBMET00536 0.133 0.043 DB00627 | DB00627 | |
| 0.077 | 0.024 | 0.077 | Transcription factor AP-1 inhibitor | 0.062 0.041 DB00627 | ||
| 0.138 | 0.085 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.118 0.109 DB00627 | ||
| 0.183 | 0.13 | 0.183 | Calpain inhibitor | 0.183 0.131 DBMET00536 0.182 0.133 DB00627 | ||
| 0.097 | 0.044 | 0.097 | Bcr-Abl kinase inhibitor | 0.086 0.056 DB00627 | ||
| 0.103 | 0.052 | 0.103 | Breast cancer-resistant protein inhibitor | |||
| 0.146 | 0.095 | 0.146 | Interleukin 6 antagonist | |||
| 0.062 | 0.012 | 0.084 | Geranyltranstransferase inhibitor | 0.073 0.006 DBMET00536 0.084 0.004 DB00627 | DB00627 | |
| 0.115 | 0.065 | 0.257 | Protein kinase (CK2) alpha inhibitor | 0.257 0.015 DB00627 | DB00627 | |
| 0.116 | 0.067 | 0.147 | Interleukin 8 antagonist | 0.125 0.055 DBMET00536 0.147 0.036 DB00627 | DB00627 | |
| 0.122 | 0.073 | 0.166 | Cathepsin H inhibitor | 0.166 0.036 DBMET00536 0.165 0.036 DB00627 | DBMET00536 | |
| 0.085 | 0.035 | 0.085 | Benzodiazepine agonist | |||
| 0.113 | 0.065 | 0.113 | Calcium channel (voltage-sensitive) blocker | |||
| 0.09 | 0.042 | 0.329 | Catalase inhibitor | 0.329 0.005 DBMET00536 0.181 0.019 DB00627 | DBMET00536 | |
| 0.06 | 0.012 | 0.075 | Guanylate cyclase inhibitor | 0.075 0.004 DBMET00536 0.069 0.005 DB00627 | DBMET00536 | |
| 0.085 | 0.038 | 0.24 | Phosphofructokinase-1 inhibitor | 0.24 0.008 DBMET00536 0.215 0.01 DB00627 | DBMET00536 | |
| 0.071 | 0.024 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 DBMET00536 0.069 0.026 DB00627 | ||
| 0.128 | 0.08 | 0.16 | CC chemokine 6 receptor antagonist | 0.16 0.012 DB00627 | DB00627 | |
| 0.058 | 0.01 | 0.062 | Diamine oxidase inhibitor | 0.046 0.017 DBMET00536 0.062 0.009 DB00627 | DB00627 | |
| 0.153 | 0.107 | 0.153 | Hepatoprotectant | 0.145 0.115 DB00627 | ||
| 0.193 | 0.147 | 0.193 | Lipoxygenase inhibitor | 0.185 0.157 DB00627 | ||
| 0.1 | 0.054 | 0.314 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.314 0.005 DBMET00536 0.282 0.007 DB00627 | DBMET00536 | |
| 0.052 | 0.006 | 0.083 | Methionyl aminopeptidase 2 inhibitor | 0.031 0.013 DBMET00536 0.083 0.004 DB00627 | DB00627 | |
| 0.071 | 0.025 | 0.106 | Thromboxane antagonist | 0.106 0.009 DB00627 | DB00627 | |
| 0.15 | 0.104 | 0.221 | DNA methyltransferase I inhibitor | 0.221 0.059 DBMET00536 0.186 0.076 DB00627 | DBMET00536 | |
| 0.11 | 0.064 | 0.11 | Interleukin 2 antagonist | 0.099 0.095 DB00627 | ||
| 0.066 | 0.022 | 0.066 | Carbonic anhydrase XIV inhibitor | 0.055 0.028 DBMET00536 0.057 0.027 DB00627 | ||
| 0.05 | 0.007 | 0.05 | Transforming growth factor beta 2 antagonist | |||
| 0.083 | 0.041 | 0.234 | Glutamate decarboxylase inhibitor | 0.21 0.006 DBMET00536 0.234 0.005 DB00627 | DB00627 | |
| 0.097 | 0.055 | 0.097 | Protein kinase C zeta inhibitor | 0.09 0.065 DBMET00536 0.093 0.061 DB00627 | ||
| 0.061 | 0.019 | 0.07 | Adenosine deaminase inhibitor | 0.07 0.013 DBMET00536 0.069 0.014 DB00627 | DBMET00536 | |
| 0.057 | 0.016 | 0.059 | Cytokine production stimulant | 0.059 0.013 DBMET00536 0.05 0.029 DB00627 | DBMET00536 | |
| 0.054 | 0.013 | 0.06 | Angiotensin AT1 receptor antagonist | 0.045 0.025 DBMET00536 0.06 0.006 DB00627 | DB00627 | |
| 0.068 | 0.028 | 0.069 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 DBMET00536 0.063 0.032 DB00627 | DBMET00536 | |
| 0.058 | 0.018 | 0.077 | Dopamine beta hydroxylase inhibitor | 0.069 0.009 DBMET00536 0.077 0.005 DB00627 | DB00627 | |
| 0.059 | 0.02 | 0.059 | Aldosterone antagonist | 0.053 0.025 DBMET00536 0.047 0.034 DB00627 | ||
| 0.063 | 0.026 | 0.091 | Thromboxane A2 antagonist | 0.091 0.01 DB00627 | DB00627 | |
| 0.045 | 0.008 | 0.045 | Epoxide hydrolase 1 inhibitor | 0.033 0.017 DBMET00536 0.038 0.013 DB00627 | ||
| 0.209 | 0.172 | 0.209 | Ca(v)3.3 blocker | |||
| 0.059 | 0.022 | 0.059 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.086 | 0.05 | 0.115 | Acetylcholine nicotinic agonist | 0.115 0.028 DB00627 | DB00627 | |
| 0.08 | 0.044 | 0.241 | Glutamate dehydrogenase inhibitor | 0.218 0.009 DBMET00536 0.241 0.008 DB00627 | DB00627 | |
| 0.044 | 0.008 | 0.077 | Kynurenine 3 monooxygenase inhibitor | 0.042 0.009 DBMET00536 0.077 0.004 DB00627 | DB00627 | |
| 0.099 | 0.063 | 0.186 | Carbonic anhydrase III inhibitor | 0.176 0.021 DBMET00536 0.186 0.019 DB00627 | DB00627 | |
| 0.152 | 0.116 | 0.217 | DNA methylase inhibitor | 0.217 0.068 DBMET00536 0.194 0.083 DB00627 | DBMET00536 | |
| 0.044 | 0.008 | 0.044 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 DBMET00536 0.038 0.012 DB00627 | ||
| 0.051 | 0.015 | 0.158 | TRPM8 blocker | 0.158 0.004 DB00627 | DB00627 | |
| 0.047 | 0.011 | 0.053 | Vanilloid 3 antagonist | 0.053 0.007 DBMET00536 0.045 0.013 DB00627 | DBMET00536 | |
| 0.081 | 0.046 | 0.081 | Acetylcholine M4 receptor antagonist | |||
| 0.145 | 0.111 | 0.145 | Platelet adhesion inhibitor | 0.143 0.114 DB00627 | ||
| 0.066 | 0.032 | 0.066 | Potassium channel Kv1.5 blocker | |||
| 0.055 | 0.022 | 0.055 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.077 | 0.043 | 0.16 | Glycine receptor agonist | 0.16 0.006 DBMET00536 0.124 0.011 DB00627 | DBMET00536 | |
| 0.057 | 0.024 | 0.066 | Squalene epoxidase inhibitor | 0.066 0.016 DBMET00536 0.049 0.035 DB00627 | DBMET00536 | |
| 0.085 | 0.052 | 0.131 | Estrogen-related receptor beta agonist | 0.131 0.006 DBMET00536 0.086 0.05 DB00627 | DBMET00536 | |
| 0.047 | 0.014 | 0.088 | Glutamate (mGluR8) agonist | 0.088 0.004 DBMET00536 0.073 0.005 DB00627 | DBMET00536 | |
| 0.048 | 0.015 | 0.214 | Nicotinic acid receptor 2 agonist | 0.214 0.004 DB00627 | DB00627 | |
| 0.102 | 0.069 | 0.159 | Falcipain 3 inhibitor | 0.159 0.032 DBMET00536 0.143 0.04 DB00627 | DBMET00536 | |
| 0.104 | 0.072 | 0.191 | Mucolytic | 0.191 0.015 DBMET00536 0.15 0.033 DB00627 | DBMET00536 | |
| 0.066 | 0.034 | 0.066 | Histone deacetylase SIRT3 inhibitor | 0.063 0.042 DB00627 | ||
| 0.234 | 0.202 | 0.234 | DNA directed DNA polymerase inhibitor | |||
| 0.04 | 0.008 | 0.04 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET00536 0.031 0.016 DB00627 | ||
| 0.091 | 0.06 | 0.104 | Polo-like kinase-1 inhibitor | 0.104 0.041 DB00627 | DB00627 | |
| 0.109 | 0.078 | 0.141 | Alkylator | 0.141 0.052 DBMET00536 0.1 0.088 DB00627 | DBMET00536 | |
| 0.098 | 0.067 | 0.098 | Vascular endothelial growth factor 1 antagonist | |||
| 0.073 | 0.043 | 0.073 | Elastase 1 inhibitor | |||
| 0.055 | 0.025 | 0.055 | Potassium channel Kv1.3 blocker | 0.051 0.028 DBMET00536 | ||
| 0.052 | 0.022 | 0.052 | Benzodiazepine inverse agonist | |||
| 0.041 | 0.011 | 0.048 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 DBMET00536 0.048 0.007 DB00627 | DB00627 | |
| 0.042 | 0.012 | 0.053 | Angiotensin II receptor antagonist | 0.033 0.026 DBMET00536 0.053 0.005 DB00627 | DB00627 | |
| 0.066 | 0.037 | 0.078 | Transcription factor RelA inhibitor | 0.078 0.019 DBMET00536 0.064 0.042 DB00627 | DBMET00536 | |
| 0.065 | 0.036 | 0.073 | Cyclin-dependent kinase 6 inhibitor | 0.057 0.045 DBMET00536 0.073 0.028 DB00627 | DB00627 | |
| 0.058 | 0.029 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.072 0.01 DBMET00536 0.058 0.029 DB00627 | DBMET00536 | |
| 0.232 | 0.203 | 0.232 | DNA polymerase beta inhibitor | |||
| 0.129 | 0.101 | 0.186 | Phospholipase A2 inhibitor | 0.138 0.088 DBMET00536 0.186 0.05 DB00627 | DB00627 | |
| 0.075 | 0.047 | 0.162 | Aminopeptidase I inhibitor | 0.15 0.012 DBMET00536 0.162 0.011 DB00627 | DB00627 | |
| 0.047 | 0.019 | 0.096 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.088 0.003 DBMET00536 0.096 0.003 DB00627 | DB00627 | |
| 0.114 | 0.086 | 0.144 | DNA repair enzyme inhibitor | 0.144 0.037 DBMET00536 0.111 0.092 DB00627 | DBMET00536 | |
| 0.076 | 0.049 | 0.076 | Adenosine A3 receptor antagonist | 0.068 0.062 DBMET00536 | ||
| 0.198 | 0.171 | 0.198 | Caspase 3 stimulant | |||
| 0.035 | 0.008 | 0.077 | Nicotinic acid receptor 2 antagonist | 0.041 0.005 DBMET00536 0.077 0.003 DB00627 | DB00627 | |
| 0.045 | 0.018 | 0.072 | Farnesoid X receptor agonist | 0.039 0.024 DBMET00536 0.072 0.007 DB00627 | DB00627 | |
| 0.11 | 0.083 | 0.11 | Cholinergic antagonist | |||
| 0.048 | 0.022 | 0.048 | GABA B receptor antagonist | 0.047 0.023 DBMET00536 0.044 0.027 DB00627 | ||
| 0.101 | 0.075 | 0.245 | Monophenol monooxygenase inhibitor | 0.245 0.025 DBMET00536 0.166 0.041 DB00627 | DBMET00536 | |
| 0.033 | 0.008 | 0.033 | Glucosylceramidase stimulant | 0.027 0.021 DB00627 | ||
| 0.198 | 0.172 | 0.198 | Angiogenesis inhibitor | |||
| 0.108 | 0.082 | 0.108 | Acetylcholine antagonist | |||
| 0.047 | 0.021 | 0.047 | DNA gyrase subunit A inhibitor | 0.042 0.03 DB00627 | ||
| 0.04 | 0.015 | 0.04 | Calcium release-activated channel blocker | |||
| 0.035 | 0.01 | 0.102 | Protocollagen prolyl hydroxylase inhibitor | 0.102 0.004 DB00627 | DB00627 | |
| 0.034 | 0.009 | 0.063 | Prostaglandin H2 antagonist | 0.029 0.014 DBMET00536 0.063 0.003 DB00627 | DB00627 | |
| 0.049 | 0.024 | 0.131 | Glutamate (mGluR group III) agonist | 0.059 0.019 DBMET00536 0.131 0.006 DB00627 | DB00627 | |
| 0.063 | 0.039 | 0.063 | TRPA1 antagonist | |||
| 0.068 | 0.044 | 0.087 | MDM2 inhibitor | 0.082 0.018 DBMET00536 0.087 0.013 DB00627 | DB00627 | |
| 0.052 | 0.028 | 0.052 | Glutamate (mGluR5) antagonist | |||
| 0.031 | 0.008 | 0.038 | Hexokinase stimulant | 0.038 0.006 DB00627 | DB00627 | |
| 0.055 | 0.032 | 0.094 | Dihydroorotate dehydrogenase inhibitor | 0.094 0.013 DB00627 | DB00627 | |
| 0.141 | 0.119 | 0.199 | Lipocortins synthesis antagonist | 0.157 0.095 DBMET00536 0.199 0.057 DB00627 | DB00627 | |
| 0.063 | 0.041 | 0.071 | Phosphodiesterase 1C inhibitor | 0.062 0.044 DBMET00536 0.071 0.028 DB00627 | DB00627 | |
| 0.143 | 0.121 | 0.23 | Phospholipase C inhibitor | 0.23 0.03 DBMET00536 0.192 0.05 DB00627 | DBMET00536 | |
| 0.128 | 0.106 | 0.16 | Cyclin-dependent kinase 8 inhibitor | 0.16 0.07 DB00627 | DB00627 | |
| 0.04 | 0.019 | 0.154 | Fumarate hydratase inhibitor | 0.154 0.004 DBMET00536 0.088 0.006 DB00627 | DBMET00536 | |
| 0.102 | 0.081 | 0.112 | Anesthetic local | 0.112 0.073 DBMET00536 | DBMET00536 | |
| 0.081 | 0.06 | 0.081 | Transforming growth factor beta 3 antagonist | |||
| 0.06 | 0.038 | 0.081 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.038 DBMET00536 0.081 0.016 DB00627 | DB00627 | |
| 0.081 | 0.06 | 0.083 | Inducible nitric-oxide synthase inhibitor | 0.083 0.057 DBMET00536 0.078 0.066 DB00627 | DBMET00536 | |
| 0.047 | 0.026 | 0.062 | AICAR transformylase inhibitor | 0.062 0.013 DBMET00536 0.055 0.017 DB00627 | DBMET00536 | |
| 0.048 | 0.027 | 0.08 | Dihydroorotase inhibitor | 0.06 0.016 DBMET00536 0.08 0.009 DB00627 | DB00627 | |
| 0.122 | 0.102 | 0.181 | Diuretic | 0.118 0.107 DBMET00536 0.181 0.053 DB00627 | DB00627 | |
| 0.089 | 0.069 | 0.089 | Platelet activating factor alpha antagonist | |||
| 0.048 | 0.028 | 0.068 | Glutamate (mGluR5) agonist | 0.068 0.014 DB00627 | DB00627 | |
| 0.061 | 0.041 | 0.067 | Aromatase inhibitor | 0.067 0.036 DB00627 | DB00627 | |
| 0.053 | 0.033 | 0.053 | H+/K+-transporting ATPase inhibitor | |||
| 0.04 | 0.02 | 0.108 | Glutamate (mGluR3) antagonist | 0.065 0.007 DBMET00536 0.108 0.004 DB00627 | DB00627 | |
| 0.039 | 0.02 | 0.121 | Retinoid X alpha receptor agonist | 0.056 0.012 DBMET00536 0.121 0.004 DB00627 | DB00627 | |
| 0.09 | 0.07 | 0.121 | MAP kinase kinase 1 inhibitor | 0.119 0.036 DBMET00536 0.121 0.034 DB00627 | DB00627 | |
| 0.157 | 0.137 | 0.224 | Platelet antagonist | 0.224 0.085 DB00627 | DB00627 | |
| 0.045 | 0.026 | 0.054 | Toll-Like receptor 2 agonist | 0.054 0.022 DBMET00536 0.037 0.032 DB00627 | DBMET00536 | |
| 0.087 | 0.068 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.196 0.012 DBMET00536 0.191 0.014 DB00627 | DBMET00536 | |
| 0.09 | 0.071 | 0.16 | Sphingomyelinase inhibitor | 0.16 0.02 DBMET00536 0.089 0.074 DB00627 | DBMET00536 | |
| 0.024 | 0.005 | 0.024 | CC chemokine 9 receptor antagonist | 0.023 0.005 DB00627 | ||
| 0.074 | 0.055 | 0.126 | GABA B receptor agonist | 0.126 0.006 DBMET00536 0.101 0.016 DB00627 | DBMET00536 | |
| 0.075 | 0.056 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 DBMET00536 0.118 0.03 DB00627 | DBMET00536 | |
| 0.093 | 0.074 | 0.149 | Anabolic | 0.149 0.018 DBMET00536 0.12 0.039 DB00627 | DBMET00536 | |
| 0.034 | 0.016 | 0.04 | Liver X receptor beta antagonist | 0.034 0.016 DBMET00536 0.04 0.013 DB00627 | DB00627 | |
| 0.126 | 0.108 | 0.18 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.023 DBMET00536 0.178 0.026 DB00627 | DBMET00536 | |
| 0.052 | 0.034 | 0.058 | Prolyl endopeptidase inhibitor | 0.045 0.044 DBMET00536 0.058 0.027 DB00627 | DB00627 | |
| 0.09 | 0.072 | 0.205 | Aminopeptidase B inhibitor | 0.194 0.023 DBMET00536 0.205 0.02 DB00627 | DB00627 | |
| 0.078 | 0.06 | 0.135 | Carbonic anhydrase VI inhibitor | 0.135 0.024 DBMET00536 0.109 0.034 DB00627 | DBMET00536 | |
| 0.06 | 0.042 | 0.072 | Cyclin D1 inhibitor | 0.072 0.026 DBMET00536 | DBMET00536 | |
| 0.04 | 0.022 | 0.103 | Retinoid X receptor agonist | 0.056 0.015 DBMET00536 0.103 0.004 DB00627 | DB00627 | |
| 0.051 | 0.034 | 0.082 | Lysophosphatidic acid 3 receptor antagonist | 0.078 0.01 DBMET00536 0.082 0.009 DB00627 | DB00627 | |
| 0.028 | 0.011 | 0.103 | Retinoic acid receptor agonist | 0.103 0.004 DB00627 | DB00627 | |
| 0.071 | 0.054 | 0.071 | Phosphodiesterase 4D inhibitor | |||
| 0.05 | 0.033 | 0.081 | Topoisomerase II beta inhibitor | 0.067 0.018 DBMET00536 0.081 0.013 DB00627 | DB00627 | |
| 0.036 | 0.02 | 0.06 | Free fatty acid receptor 1 antagonist | 0.046 0.011 DBMET00536 0.06 0.005 DB00627 | DB00627 | |
| 0.028 | 0.012 | 0.114 | Retinoid X gamma receptor agonist | 0.114 0.003 DB00627 | DB00627 | |
| 0.079 | 0.063 | 0.101 | Glutathione S-transferase inhibitor | 0.101 0.036 DBMET00536 0.086 0.053 DB00627 | DBMET00536 | |
| 0.04 | 0.025 | 0.092 | Retinoic acid alpha receptor agonist | 0.092 0.004 DB00627 | DB00627 | |
| 0.184 | 0.169 | 0.184 | Prostaglandin dehydrogenase inhibitor | |||
| 0.076 | 0.061 | 0.076 | Platelet growth factor antagonist | |||
| 0.064 | 0.049 | 0.073 | Beta adrenoreceptor antagonist | 0.073 0.034 DBMET00536 0.061 0.053 DB00627 | DBMET00536 | |
| 0.036 | 0.021 | 0.076 | Glutamate (mGluR4) agonist | 0.037 0.019 DBMET00536 0.076 0.006 DB00627 | DB00627 | |
| 0.123 | 0.11 | 0.145 | Thiol protease inhibitor | 0.13 0.096 DBMET00536 0.145 0.074 DB00627 | DB00627 | |
| 0.092 | 0.079 | 0.18 | Expectorant | 0.18 0.025 DBMET00536 0.122 0.049 DB00627 | DBMET00536 | |
| 0.053 | 0.04 | 0.199 | Acyl-CoA dehydrogenase inhibitor | 0.199 0.005 DBMET00536 0.159 0.008 DB00627 | DBMET00536 | |
| 0.047 | 0.034 | 0.083 | Glutamate (mGluR group I) agonist | 0.083 0.012 DB00627 | DB00627 | |
| 0.083 | 0.07 | 0.083 | Phosphodiesterase I inhibitor | 0.081 0.075 DBMET00536 0.079 0.078 DB00627 | ||
| 0.113 | 0.101 | 0.21 | Protein kinase stimulant | 0.21 0.038 DBMET00536 | DBMET00536 | |
| 0.048 | 0.036 | 0.048 | Phosphodiesterase 4A inhibitor | |||
| 0.052 | 0.041 | 0.071 | Myc inhibitor | 0.071 0.018 DB00627 | DB00627 | |
| 0.069 | 0.058 | 0.069 | Orexin receptor 1 antagonist | |||
| 0.145 | 0.135 | 0.194 | EphB2 antagonist | 0.194 0.092 DB00627 | DB00627 | |
| 0.033 | 0.023 | 0.07 | Protein kinase (CK2) beta inhibitor | 0.038 0.015 DBMET00536 0.07 0.004 DB00627 | DB00627 | |
| 0.042 | 0.032 | 0.05 | Heme oxygenase inhibitor | 0.05 0.014 DBMET00536 0.044 0.026 DB00627 | DBMET00536 | |
| 0.072 | 0.061 | 0.204 | Glutamate receptor agonist | 0.204 0.01 DB00627 | DB00627 | |
| 0.106 | 0.096 | 0.106 | Tubulin antagonist | |||
| 0.018 | 0.008 | 0.018 | Nicotinic alpha4 receptor agonist | |||
| 0.052 | 0.043 | 0.052 | Phosphodiesterase 4C inhibitor | |||
| 0.068 | 0.059 | 0.068 | Rho-associated kinase I inhibitor | |||
| 0.017 | 0.008 | 0.023 | Angiotensin AT1B receptor antagonist | 0.023 0.005 DB00627 | DB00627 | |
| 0.027 | 0.018 | 0.027 | Calcium-sensing receptor agonist | 0.025 0.021 DBMET00536 0.027 0.017 DB00627 | ||
| 0.15 | 0.141 | 0.191 | Growth factor agonist | 0.191 0.072 DB00627 | DB00627 | |
| 0.033 | 0.024 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.013 DBMET00536 | DBMET00536 | |
| 0.046 | 0.037 | 0.128 | Glucose-6-phosphate isomerase inhibitor | 0.128 0.003 DBMET00536 0.067 0.014 DB00627 | DBMET00536 | |
| 0.041 | 0.032 | 0.041 | Leukocyte elastase inhibitor | |||
| 0.064 | 0.056 | 0.064 | MAP kinase kinase 8 inhibitor | |||
| 0.019 | 0.011 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.029 | 0.022 | 0.043 | DNA topoisomerase IV inhibitor | 0.043 0.007 DB00627 | DB00627 | |
| 0.062 | 0.055 | 0.083 | CDC7 inhibitor | 0.083 0.034 DB00627 | DB00627 | |
| 0.023 | 0.016 | 0.03 | ICAM 1 antagonist | 0.021 0.02 DBMET00536 0.03 0.007 DB00627 | DB00627 | |
| 0.073 | 0.067 | 0.125 | Adrenaline agonist | 0.077 0.062 DBMET00536 0.125 0.023 DB00627 | DB00627 | |
| 0.036 | 0.03 | 0.065 | Retinoid X receptor antagonist | 0.051 0.012 DBMET00536 0.065 0.005 DB00627 | DB00627 | |
| 0.056 | 0.05 | 0.138 | Purinergic P2X1 antagonist | 0.138 0.009 DBMET00536 0.138 0.008 DB00627 | DB00627 | |
| 0.201 | 0.196 | 0.275 | Immunosuppressant | 0.275 0.131 DB00627 | DB00627 | |
| 0.216 | 0.211 | 0.369 | Antibacterial | 0.231 0.195 DBMET00536 0.369 0.092 DB00627 | DB00627 | |
| 0.027 | 0.021 | 0.043 | Hedgehog signaling activator | 0.043 0.004 DBMET00536 0.027 0.021 DB00627 | DBMET00536 | |
| 0.056 | 0.051 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.047 DB00627 | DB00627 | |
| 0.08 | 0.075 | 0.104 | Potassium channel activator | 0.104 0.044 DB00627 | DB00627 | |
| 0.017 | 0.013 | 0.058 | Nicotinic acid receptor 1 antagonist | 0.024 0.005 DBMET00536 0.058 0.002 DB00627 | DB00627 | |
| 0.056 | 0.051 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.112 | 0.107 | 0.112 | Activin receptor-like kinase 2 inhibitor | |||
| 0.051 | 0.047 | 0.089 | Dihydroorotate oxidase inhibitor | 0.089 0.007 DBMET00536 0.084 0.009 DB00627 | DBMET00536 | |
| 0.049 | 0.045 | 0.089 | Carbonic anhydrase VB inhibitor | 0.089 0.019 DBMET00536 0.077 0.024 DB00627 | DBMET00536 | |
| 0.046 | 0.042 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.029 DBMET00536 0.052 0.033 DB00627 | DBMET00536 | |
| 0.014 | 0.011 | 0.058 | Egl nine homolog 1 inhibitor | 0.058 0.003 DB00627 | DB00627 | |
| 0.032 | 0.028 | 0.056 | Retinoid X alpha receptor antagonist | 0.044 0.01 DBMET00536 0.056 0.004 DB00627 | DB00627 | |
| 0.059 | 0.056 | 0.093 | Interferon inducer | 0.093 0.016 DBMET00536 | DBMET00536 | |
| 0.119 | 0.116 | 0.119 | MAP3K9 inhibitor | |||
| 0.016 | 0.013 | 0.045 | Carbonic anhydrase VIII inhibitor | 0.045 0.003 DBMET00536 0.02 0.008 DB00627 | DBMET00536 | |
| 0.016 | 0.013 | 0.045 | Carbonic anhydrase X inhibitor | 0.045 0.003 DBMET00536 0.02 0.008 DB00627 | DBMET00536 | |
| 0.037 | 0.034 | 0.041 | Liver X receptor alpha agonist | 0.041 0.029 DBMET00536 0.038 0.032 DB00627 | DBMET00536 | |
| 0.018 | 0.015 | 0.019 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.019 0.014 DB00627 | DB00627 | |
| 0.041 | 0.038 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.03 DBMET00536 0.043 0.032 DB00627 | DBMET00536 | |
| 0.053 | 0.051 | 0.239 | Carbamoyl phosphate synthetase inhibitor | 0.239 0.006 DBMET00536 0.103 0.02 DB00627 | DBMET00536 | |
| 0.027 | 0.025 | 0.031 | MAP3K8 inhibitor | 0.031 0.015 DB00627 | DB00627 | |
| 0.025 | 0.023 | 0.061 | Uridine phosphorylase inhibitor | 0.059 0.006 DBMET00536 0.061 0.005 DB00627 | DB00627 | |
| 0.096 | 0.094 | 0.102 | Proteasome inhibitor | 0.102 0.084 DBMET00536 | DBMET00536 | |
| 0.096 | 0.094 | 0.096 | Activin receptor-like kinase 4 inhibitor | |||
| 0.066 | 0.064 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.053 DBMET00536 0.088 0.024 DB00627 | DB00627 | |
| 0.042 | 0.041 | 0.14 | AMPA receptor antagonist | 0.14 0.007 DB00627 | DB00627 | |
| 0.013 | 0.011 | 0.013 | Cyclin D2 inhibitor | |||
| 0.078 | 0.077 | 0.083 | Interleukin 5 antagonist | 0.083 0.066 DB00627 | DB00627 | |
| 0.077 | 0.076 | 0.129 | D-Ala-D-Ala ligase inhibitor | 0.129 0.01 DBMET00536 0.113 0.017 DB00627 | DBMET00536 | |
| 0.019 | 0.018 | 0.039 | Retinoid X beta receptor antagonist | 0.027 0.005 DBMET00536 0.039 0.003 DB00627 | DB00627 | |
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.011 | 0.01 | 0.037 | Egl nine homolog 3 inhibitor | 0.013 0.007 DBMET00536 0.037 0.003 DB00627 | DB00627 | |
| 0.039 | 0.038 | 0.062 | Purinergic P2Y antagonist | 0.062 0.018 DB00627 | DB00627 | |
| 0.035 | 0.034 | 0.037 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET00536 0.035 0.034 DB00627 | DBMET00536 | |
| 0.049 | 0.049 | 0.188 | Argininosuccinate synthase inhibitor | 0.188 0.008 DBMET00536 0.178 0.009 DB00627 | DBMET00536 | |
| 0.035 | 0.035 | 0.06 | Dihydropteroate synthase inhibitor | 0.06 0.011 DBMET00536 0.054 0.014 DB00627 | DBMET00536 | |
| 0.058 | 0.059 | 0.066 | Aryl hydrocarbon receptor antagonist | 0.066 0.043 DBMET00536 | DBMET00536 | |
| 0.03 | 0.031 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | 0.036 0.021 DBMET00536 0.044 0.012 DB00627 | DB00627 | |
| 0.03 | 0.031 | 0.044 | Carnitine palmitoyltransferase inhibitor | 0.035 0.022 DBMET00536 0.044 0.012 DB00627 | DB00627 | |
| 0.038 | 0.039 | 0.081 | Kainate receptor agonist | 0.081 0.004 DBMET00536 0.059 0.007 DB00627 | DBMET00536 | |
| 0.012 | 0.013 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET00536 0.014 0.008 DB00627 | DBMET00536 | |
| 0.02 | 0.022 | 0.039 | Retinoic acid gamma receptor agonist | 0.039 0.004 DB00627 | DB00627 | |
| 0.015 | 0.017 | 0.02 | Cyclin T1 inhibitor | 0.02 0.01 DBMET00536 | DBMET00536 | |
| 0.033 | 0.035 | 0.058 | Glutamate (mGluR group II) antagonist | 0.058 0.012 DB00627 | DB00627 | |
| 0.018 | 0.02 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.017 DBMET00536 | DBMET00536 | |
| 0.098 | 0.099 | 0.225 | Glutamate receptor antagonist | 0.225 0.02 DB00627 | DB00627 | |
| 0.143 | 0.145 | 0.264 | Hypolipemic | 0.264 0.061 DB00627 | DB00627 | |
| 0.031 | 0.033 | 0.034 | Inosine monophosphate dehydrogenase inhibitor | 0.034 0.029 DBMET00536 | DBMET00536 | |
| 0.082 | 0.084 | 0.239 | Creatine kinase inhibitor | 0.239 0.006 DBMET00536 0.211 0.009 DB00627 | DBMET00536 | |
| 0.045 | 0.047 | 0.057 | Potassium channel (Inward rectifier) activator | 0.057 0.023 DBMET00536 | DBMET00536 | |
| 0.025 | 0.027 | 0.043 | Retinoid X gamma receptor antagonist | 0.043 0.004 DB00627 | DB00627 | |
| 0.045 | 0.048 | 0.056 | CD45 antagonist | 0.054 0.028 DBMET00536 0.056 0.025 DB00627 | DB00627 | |
| 0.064 | 0.066 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 DBMET00536 0.073 0.057 DB00627 | DBMET00536 | |
| 0.072 | 0.074 | 0.102 | MAP kinase kinase 7 inhibitor | 0.102 0.011 DBMET00536 0.087 0.029 DB00627 | DBMET00536 | |
| 0.023 | 0.026 | 0.03 | Complement factor 1s inhibitor | 0.03 0.008 DBMET00536 | DBMET00536 | |
| 0.043 | 0.046 | 0.054 | Potassium channel (ATP-sensitive) activator | 0.054 0.023 DBMET00536 | DBMET00536 | |
| 0.11 | 0.113 | 0.157 | Vanilloid 1 agonist | 0.157 0.032 DBMET00536 | DBMET00536 | |
| 0.016 | 0.019 | 0.018 | Complement factor D inhibitor | 0.018 0.013 DBMET00536 | DBMET00536 | |
| 0.009 | 0.013 | 0.072 | Retinoic acid beta receptor antagonist | 0.072 0.003 DB00627 | DB00627 | |
| 0.015 | 0.019 | 0.067 | Retinoic acid receptor antagonist | 0.067 0.004 DB00627 | DB00627 | |
| 0.049 | 0.054 | 0.061 | Fatty acid synthase inhibitor | 0.061 0.034 DB00627 | DB00627 | |
| 0.017 | 0.022 | 0.087 | Retinoid X beta receptor agonist | 0.087 0.004 DB00627 | DB00627 | |
| 0.047 | 0.053 | 0.065 | Heparanase inhibitor | 0.065 0.017 DBMET00536 0.064 0.017 DB00627 | DBMET00536 | |
| 0.025 | 0.03 | 0.037 | Glutamate (mGluR2) antagonist | 0.037 0.013 DB00627 | DB00627 | |
| 0.078 | 0.084 | 0.243 | Alcohol dehydrogenase inhibitor | 0.13 0.028 DBMET00536 0.243 0.008 DB00627 | DB00627 | |
| 0.036 | 0.042 | 0.049 | Histamine H2 receptor agonist | 0.049 0.022 DBMET00536 | DBMET00536 | |
| 0.042 | 0.048 | 0.053 | Beta adrenoreceptor agonist | 0.043 0.042 DBMET00536 0.053 0.014 DB00627 | DB00627 | |
| 0.038 | 0.046 | 0.046 | Histamine H1 receptor agonist | 0.046 0.025 DBMET00536 0.04 0.039 DB00627 | DBMET00536 | |
| 0.048 | 0.055 | 0.061 | Epithelial sodium channel blocker | 0.061 0.028 DBMET00536 | DBMET00536 | |
| 0.022 | 0.03 | 0.077 | NMDA 2D receptor antagonist | 0.077 0.004 DB00627 | DB00627 | |
| 0.009 | 0.017 | 0.054 | Retinoic acid receptor gamma antagonist | 0.054 0.003 DB00627 | DB00627 | |
| 0.045 | 0.053 | 0.061 | Protein kinase C eta inhibitor | 0.061 0.033 DB00627 | DB00627 | |
| 0.068 | 0.076 | 0.111 | Interferon agonist | 0.111 0.021 DBMET00536 | DBMET00536 | |
| 0.016 | 0.025 | 0.05 | Retinoic acid beta receptor agonist | 0.05 0.004 DB00627 | DB00627 | |
| 0.092 | 0.1 | 0.096 | CDC-like kinase 3 inhibitor | 0.096 0.088 DB00627 | DB00627 | |
| 0.025 | 0.034 | 0.034 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET00536 | DBMET00536 | |
| 0.009 | 0.018 | 0.036 | Lysophosphatidic acid receptor 3 agonist | 0.036 0.003 DBMET00536 | DBMET00536 | |
| 0.02 | 0.031 | 0.045 | Lysophosphatidic acid receptor 1 agonist | 0.045 0.004 DBMET00536 0.023 0.022 DB00627 | DBMET00536 | |
| 0.083 | 0.093 | 0.109 | Bile acid receptor antagonist | 0.108 0.033 DBMET00536 0.109 0.033 DB00627 | DB00627 | |
| 0.015 | 0.027 | 0.027 | Antibiotic Anthracycline-like | 0.027 0.004 DBMET00536 | DBMET00536 | |
| 0.111 | 0.122 | 0.167 | Sphingosine 1-phosphate receptor 2 antagonist | 0.167 0.024 DBMET00536 0.14 0.055 DB00627 | DBMET00536 | |
| 0.006 | 0.019 | 0.017 | Beta 3 adrenoreceptor agonist | 0.017 0.005 DB00627 | DB00627 | |
| 0.111 | 0.123 | 0.122 | Acetylcholine M1 receptor antagonist | 0.122 0.106 DBMET00536 | DBMET00536 | |
| 0.044 | 0.057 | 0.113 | Alpha-mannosidase inhibitor | 0.113 0.005 DBMET00536 0.05 0.043 DB00627 | DBMET00536 | |
| 0.036 | 0.05 | 0.086 | Guanylate cyclase stimulant | 0.086 0.008 DB00627 | DB00627 | |
| 0.023 | 0.037 | 0.047 | Purinergic P2Y15 antagonist | 0.047 0.004 DBMET00536 0.028 0.021 DB00627 | DBMET00536 | |
| 0.016 | 0.031 | 0.031 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 DBMET00536 0.031 0.006 DB00627 | DB00627 | |
| 0.077 | 0.092 | 0.267 | Uric acid excretion stimulant | 0.267 0.006 DB00627 | DB00627 | |
| 0.09 | 0.107 | 0.268 | Amylase inhibitor | 0.268 0.023 DBMET00536 0.143 0.068 DB00627 | DBMET00536 | |
| 0.03 | 0.047 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 DBMET00536 0.045 0.009 DB00627 | DBMET00536 | |
| 0.141 | 0.159 | 0.192 | Antiamyloidogenic | 0.192 0.105 DB00627 | DB00627 | |
| 0.038 | 0.056 | 0.046 | Potassium channel (Inward rectifier) blocker | 0.046 0.04 DBMET00536 | DBMET00536 | |
| 0.025 | 0.042 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.01 DBMET00536 0.046 0.016 DB00627 | DBMET00536 | |
| 0.062 | 0.08 | 0.092 | Histamine H1 receptor antagonist | 0.092 0.046 DB00627 | DB00627 | |
| 0.073 | 0.091 | 0.116 | mTOR complex 2 inhibitor | 0.116 0.02 DBMET00536 | DBMET00536 | |
| 0.021 | 0.038 | 0.04 | LFA antagonist | 0.04 0.008 DB00627 | DB00627 | |
| 0.042 | 0.06 | 0.055 | Glucose-6-phosphate translocase inhibitor | 0.055 0.03 DB00627 | DB00627 | |
| 0.045 | 0.064 | 0.104 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.067 0.033 DBMET00536 0.104 0.016 DB00627 | DB00627 | |
| 0.06 | 0.079 | 0.102 | Phospholipase D inhibitor | 0.102 0.013 DBMET00536 0.092 0.02 DB00627 | DBMET00536 | |
| 0.015 | 0.034 | 0.048 | Glutamate (mGluR1a) agonist | 0.048 0.005 DBMET00536 0.036 0.006 DB00627 | DBMET00536 | |
| 0.097 | 0.117 | 0.129 | Transcription factor STAT6 inhibitor | 0.122 0.056 DBMET00536 0.129 0.045 DB00627 | DB00627 | |
| 0.025 | 0.046 | 0.063 | RNA-directed RNA polymerase inhibitor | 0.063 0.009 DB00627 | DB00627 | |
| 0.013 | 0.033 | 0.049 | Retinoic acid alpha receptor antagonist | 0.049 0.004 DB00627 | DB00627 | |
| 0.049 | 0.07 | 0.107 | Sphingosine 1-phosphate receptor 4 agonist | 0.107 0.022 DBMET00536 0.076 0.04 DB00627 | DBMET00536 | |
| 0.045 | 0.066 | 0.084 | Carbonic anhydrase stimulant | 0.084 0.024 DBMET00536 0.067 0.034 DB00627 | DBMET00536 | |
| 0.007 | 0.028 | 0.014 | Egl nine homolog 2 inhibitor | 0.014 0.006 DB00627 | DB00627 | |
| 0.006 | 0.029 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00536 | DBMET00536 | |
| 0.014 | 0.037 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET00536 0.021 0.008 DB00627 | DBMET00536 | |
| 0.049 | 0.072 | 0.065 | Leukotriene C antagonist | 0.061 0.028 DBMET00536 0.065 0.019 DB00627 | DB00627 | |
| 0.015 | 0.038 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 DBMET00536 0.024 0.009 DB00627 | DBMET00536 | |
| 0.034 | 0.057 | 0.048 | CF transmembrane conductance regulator antagonist | 0.043 0.019 DBMET00536 0.048 0.01 DB00627 | DB00627 | |
| 0.12 | 0.144 | 0.133 | Antipruritic | 0.133 0.117 DB00627 | DB00627 | |
| 0.02 | 0.044 | 0.053 | HCV NS5B polymerase inhibitor | 0.053 0.009 DB00627 | DB00627 | |
| 0.006 | 0.031 | 0.016 | Thrombopoietin agonist | 0.016 0.005 DB00627 | DB00627 | |
| 0.007 | 0.032 | 0.018 | Carbonic anhydrase XI inhibitor | 0.018 0.005 DBMET00536 | DBMET00536 | |
| 0.044 | 0.07 | 0.057 | Collagenase 3 inhibitor | 0.057 0.045 DB00627 | DB00627 | |
| 0.021 | 0.047 | 0.031 | Calcitonin receptor agonist | 0.031 0.025 DBMET00536 | DBMET00536 | |
| 0.057 | 0.083 | 0.075 | Secretase beta inhibitor | 0.075 0.043 DBMET00536 | DBMET00536 | |
| 0.016 | 0.043 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET00536 | DBMET00536 | |
| 0.044 | 0.072 | 0.054 | Acetylcholine M5 receptor antagonist | 0.054 0.052 DBMET00536 | DBMET00536 | |
| 0.055 | 0.083 | 0.094 | Epoxide hydrolase inhibitor | 0.094 0.029 DBMET00536 | DBMET00536 | |
| 0.005 | 0.034 | 0.025 | Glutamate (mGluR6) agonist | 0.025 0.004 DBMET00536 0.016 0.005 DB00627 | DBMET00536 | |
| 0.031 | 0.06 | 0.051 | Stearoyl-CoA desaturase inhibitor | 0.051 0.023 DB00627 | DB00627 | |
| 0.028 | 0.057 | 0.067 | Phosphorylase inhibitor | 0.067 0.021 DB00627 | DB00627 | |
| 0.047 | 0.076 | 0.067 | Heat shock protein 90 beta antagonist | 0.067 0.031 DBMET00536 | DBMET00536 | |
| 0.031 | 0.061 | 0.101 | Mannosidase inhibitor | 0.101 0.005 DBMET00536 0.048 0.028 DB00627 | DBMET00536 | |
| 0.019 | 0.05 | 0.095 | Kainate receptor 2 antagonist | 0.044 0.019 DBMET00536 0.095 0.005 DB00627 | DB00627 | |
| 0.033 | 0.063 | 0.126 | Ornithine carbamoyltransferase inhibitor | 0.126 0.012 DBMET00536 0.102 0.016 DB00627 | DBMET00536 | |
| 0.079 | 0.11 | 0.161 | AMP-activated protein kinase stimulant | 0.108 0.061 DBMET00536 0.161 0.022 DB00627 | DB00627 | |
| 0.007 | 0.038 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET00536 | DBMET00536 | |
| 0.084 | 0.117 | 0.12 | MAP kinase kinase inhibitor | 0.098 0.097 DBMET00536 0.12 0.073 DB00627 | DB00627 | |
| 0.015 | 0.047 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.012 DBMET00536 | DBMET00536 | |
| 0.045 | 0.078 | 0.092 | Carbonic anhydrase V inhibitor | 0.092 0.03 DBMET00536 0.071 0.042 DB00627 | DBMET00536 | |
| 0.006 | 0.039 | 0.016 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET00536 | DBMET00536 | |
| 0.014 | 0.047 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 DB00627 | DB00627 | |
| 0.017 | 0.051 | 0.039 | Glutamate (mGluR1) agonist | 0.031 0.009 DBMET00536 0.039 0.005 DB00627 | DB00627 | |
| 0.055 | 0.089 | 0.091 | Calcium channel P-type blocker | 0.091 0.008 DBMET00536 | DBMET00536 | |
| 0.003 | 0.037 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET00536 | DBMET00536 | |
| 0.022 | 0.056 | 0.105 | Kainate receptor antagonist | 0.038 0.031 DBMET00536 0.105 0.007 DB00627 | DB00627 | |
| 0.031 | 0.065 | 0.054 | Fructose-1,6-bisphosphatase inhibitor | 0.054 0.022 DBMET00536 | DBMET00536 | |
| 0.024 | 0.059 | 0.035 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET00536 0.035 0.02 DB00627 | DB00627 | |
| 0.03 | 0.065 | 0.039 | Plasmepsin II inhibitor | 0.039 0.034 DBMET00536 | DBMET00536 | |
| 0.045 | 0.081 | 0.085 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET00536 0.085 0.007 DB00627 | DB00627 | |
| 0.006 | 0.042 | 0.018 | Peroxisome proliferator-activated receptor alpha antagonist | 0.018 0.017 DB00627 | DB00627 | |
| 0.017 | 0.053 | 0.037 | Vanilloid 2 agonist | 0.037 0.005 DBMET00536 0.028 0.012 DB00627 | DBMET00536 | |
| 0.006 | 0.043 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | 0.012 0.011 DB00627 | DB00627 | |
| 0.046 | 0.083 | 0.069 | Leukotriene synthesis inhibitor | 0.069 0.045 DB00627 | DB00627 | |
| 0.024 | 0.062 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 DBMET00536 0.041 0.009 DB00627 | DBMET00536 | |
| 0.039 | 0.078 | 0.076 | Selectin antagonist | 0.076 0.039 DB00627 | DB00627 | |
| 0.026 | 0.065 | 0.04 | MAP3K5 inhibitor | 0.04 0.025 DBMET00536 | DBMET00536 | |
| 0.028 | 0.067 | 0.048 | Antimetabolite | 0.045 0.035 DBMET00536 0.048 0.033 DB00627 | DB00627 | |
| 0.05 | 0.09 | 0.085 | Cathepsin G inhibitor | 0.085 0.04 DBMET00536 | DBMET00536 | |
| 0.007 | 0.047 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET00536 | DBMET00536 | |
| 0.01 | 0.05 | 0.027 | Telomerase stimulant | 0.027 0.004 DBMET00536 | DBMET00536 | |
| 0.038 | 0.079 | 0.129 | Glutamate (mGluR) agonist | 0.129 0.017 DB00627 | DB00627 | |
| 0.016 | 0.057 | 0.035 | Prostaglandin agonist | 0.03 0.023 DBMET00536 0.035 0.017 DB00627 | DB00627 | |
| 0.037 | 0.078 | 0.092 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.092 0.012 DBMET00536 0.072 0.02 DB00627 | DBMET00536 | |
| 0.048 | 0.089 | 0.07 | Protease 3C (Human rhinovirus) inhibitor | 0.07 0.036 DBMET00536 | DBMET00536 | |
| 0.008 | 0.05 | 0.024 | Thromboxane A2 agonist | 0.024 0.004 DBMET00536 | DBMET00536 | |
| 0.025 | 0.067 | 0.062 | Membrane dipeptidase inhibitor | 0.062 0.009 DBMET00536 0.047 0.018 DB00627 | DBMET00536 | |
| 0.032 | 0.074 | 0.132 | Plasminogen activator inhibitor antagonist | 0.132 0.006 DB00627 | DB00627 | |
| 0.014 | 0.056 | 0.038 | Lysine carboxypeptidase inhibitor | 0.038 0.011 DBMET00536 0.03 0.016 DB00627 | DBMET00536 | |
| 0.038 | 0.08 | 0.111 | NMDA receptor glycine site agonist | 0.111 0.012 DBMET00536 0.084 0.026 DB00627 | DBMET00536 | |
| 0.044 | 0.088 | 0.113 | NMDA receptor agonist | 0.113 0.015 DBMET00536 0.103 0.018 DB00627 | DBMET00536 | |
| 0.009 | 0.053 | 0.035 | Prostaglandin EP2 agonist | 0.019 0.018 DBMET00536 0.035 0.01 DB00627 | DB00627 | |
| 0.072 | 0.117 | 0.09 | Nitric-oxide synthase inhibitor | 0.09 0.077 DBMET00536 | DBMET00536 | |
| 0.042 | 0.088 | 0.075 | Leukotriene antagonist | 0.075 0.036 DB00627 | DB00627 | |
| 0.018 | 0.063 | 0.083 | Purinergic P2Y14 antagonist | 0.083 0.004 DB00627 | DB00627 | |
| 0.046 | 0.091 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 DBMET00536 | DBMET00536 | |
| 0.01 | 0.055 | 0.05 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.05 0.009 DBMET00536 | DBMET00536 | |
| 0.021 | 0.067 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.041 0.015 DB00627 | DB00627 | |
| 0.045 | 0.091 | 0.092 | Carbonic anhydrase VA inhibitor | 0.092 0.029 DBMET00536 0.077 0.039 DB00627 | DBMET00536 | |
| 0.16 | 0.206 | 0.213 | Neuropeptide Y2 antagonist | 0.213 0.099 DBMET00536 | DBMET00536 | |
| 0.032 | 0.08 | 0.066 | Maillard reaction inhibitor | 0.066 0.031 DB00627 | DB00627 | |
| 0.026 | 0.073 | 0.058 | Ribonucleoside-diphosphate reductase inhibitor | 0.058 0.035 DB00627 | DB00627 | |
| 0.02 | 0.07 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.01 DBMET00536 | DBMET00536 | |
| 0.027 | 0.077 | 0.05 | Sphingosine 1-phosphate receptor agonist | 0.04 0.037 DBMET00536 0.05 0.025 DB00627 | DB00627 | |
| 0.017 | 0.068 | 0.031 | Integrin alpha2beta1 antagonist | 0.031 0.011 DBMET00536 0.029 0.014 DB00627 | DBMET00536 | |
| 0.018 | 0.07 | 0.04 | ATP citrate lysase inhibitor | 0.04 0.013 DBMET00536 | DBMET00536 | |
| 0.025 | 0.076 | 0.058 | Ribonucleotide reductase inhibitor | 0.058 0.037 DB00627 | DB00627 | |
| 0.057 | 0.108 | 0.131 | Glycine receptor antagonist | 0.131 0.013 DBMET00536 | DBMET00536 | |
| 0.013 | 0.064 | 0.032 | Prostaglandin F2 alpha agonist | 0.032 0.008 DBMET00536 | DBMET00536 | |
| 0.035 | 0.087 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.03 DBMET00536 0.045 0.041 DB00627 | DBMET00536 | |
| 0.013 | 0.065 | 0.03 | Prostaglandin EP4 antagonist | 0.03 0.015 DB00627 | DB00627 | |
| 0.011 | 0.063 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.015 DB00627 | DB00627 | |
| 0.012 | 0.065 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.012 DB00627 | DB00627 | |
| 0.01 | 0.064 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 DB00627 | DB00627 | |
| 0.017 | 0.071 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DBMET00536 | DBMET00536 | |
| 0.06 | 0.114 | 0.117 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.117 0.026 DB00627 | DB00627 | |
| 0.061 | 0.116 | 0.119 | Urease inhibitor | 0.119 0.045 DBMET00536 0.109 0.056 DB00627 | DBMET00536 | |
| 0.022 | 0.076 | 0.03 | Protein kinase C beta II inhibitor | 0.03 0.029 DB00627 | DB00627 | |
| 0.008 | 0.063 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET00536 | DBMET00536 | |
| 0.042 | 0.099 | 0.063 | CDC25B inhibitor | 0.063 0.046 DB00627 | DB00627 | |
| 0.232 | 0.289 | 0.39 | Antiinflammatory | 0.39 0.145 DB00627 | DB00627 | |
| 0.023 | 0.081 | 0.07 | GABA uptake inhibitor | 0.07 0.007 DBMET00536 0.063 0.009 DB00627 | DBMET00536 | |
| 0.016 | 0.074 | 0.025 | Acid ceramidase inhibitor | 0.025 0.019 DBMET00536 | DBMET00536 | |
| 0.011 | 0.07 | 0.023 | Bombesin agonist | 0.023 0.015 DB00627 | DB00627 | |
| 0.057 | 0.115 | 0.094 | Cell adhesion molecule inhibitor | 0.094 0.039 DB00627 | DB00627 | |
| 0.005 | 0.064 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET00536 | DBMET00536 | |
| 0.009 | 0.071 | 0.022 | NMDA receptor glycine site antagonist | 0.022 0.02 DB00627 | DB00627 | |
| 0.03 | 0.092 | 0.059 | Diacylglycerol O-acyltransferase inhibitor | 0.059 0.027 DB00627 | DB00627 | |
| 0.029 | 0.091 | 0.042 | Leukotriene C4 antagonist | 0.039 0.026 DBMET00536 0.042 0.02 DB00627 | DB00627 | |
| 0.023 | 0.085 | 0.045 | Integrin alpha2 antagonist | 0.045 0.015 DBMET00536 0.039 0.021 DB00627 | DBMET00536 | |
| 0.012 | 0.076 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 DBMET00536 | DBMET00536 | |
| 0.033 | 0.097 | 0.052 | Leukotriene B4 antagonist | 0.051 0.042 DBMET00536 0.052 0.039 DB00627 | DB00627 | |
| 0.005 | 0.07 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.014 DBMET00536 | DBMET00536 | |
| 0.067 | 0.132 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.064 DB00627 | DB00627 | |
| 0.052 | 0.118 | 0.098 | Myeloperoxidase inhibitor | 0.098 0.038 DBMET00536 0.087 0.054 DB00627 | DBMET00536 | |
| 0.204 | 0.27 | 0.53 | Cyclophilin D inhibitor | 0.53 0.042 DB00627 | DB00627 | |
| 0.02 | 0.086 | 0.032 | Purinergic P2Y2 antagonist | 0.032 0.027 DB00627 | DB00627 | |
| 0.007 | 0.073 | 0.022 | Prostaglandin E2 agonist | 0.022 0.018 DB00627 | DB00627 | |
| 0.002 | 0.07 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET00536 | DBMET00536 | |
| 0.003 | 0.072 | 0.012 | Thromboxane agonist | 0.012 0.007 DBMET00536 | DBMET00536 | |
| 0.058 | 0.126 | 0.073 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.061 DB00627 | DB00627 | |
| 0.066 | 0.135 | 0.168 | 5 Hydroxytryptamine 3A agonist | 0.168 0.026 DBMET00536 | DBMET00536 | |
| 0.119 | 0.188 | 0.23 | Immunostimulant | 0.23 0.105 DBMET00536 0.164 0.143 DB00627 | DBMET00536 | |
| 0.097 | 0.166 | 0.182 | Dual specificity phosphatase 3 inhibitor | 0.182 0.072 DB00627 | DB00627 | |
| 0.042 | 0.112 | 0.11 | Neuraminidase (influenza) inhibitor | 0.11 0.014 DB00627 | DB00627 | |
| 0.009 | 0.08 | 0.057 | Arginase inhibitor | 0.057 0.011 DBMET00536 0.045 0.018 DB00627 | DBMET00536 | |
| 0.059 | 0.13 | 0.171 | Prolactin inhibitor | 0.171 0.015 DBMET00536 0.082 0.078 DB00627 | DBMET00536 | |
| 0.005 | 0.077 | 0.06 | AMPA 1 receptor antagonist | 0.06 0.009 DB00627 | DB00627 | |
| 0.006 | 0.079 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.012 DBMET00536 | DBMET00536 | |
| 0.019 | 0.092 | 0.055 | Oxytocin agonist | 0.055 0.021 DBMET00536 | DBMET00536 | |
| 0.027 | 0.1 | 0.086 | Adenylate cyclase 1 inhibitor | 0.086 0.006 DBMET00536 | DBMET00536 | |
| 0.079 | 0.154 | 0.125 | Cell adhesion inhibitor | 0.125 0.062 DB00627 | DB00627 | |
| 0.02 | 0.095 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.014 DBMET00536 | DBMET00536 | |
| 0.007 | 0.082 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 DBMET00536 | DBMET00536 | |
| 0.013 | 0.09 | 0.029 | Potassium channel small-conductance Ca-activated activator | 0.029 0.024 DBMET00536 | DBMET00536 | |
| 0.031 | 0.108 | 0.051 | HCV NS3/NS4A protease inhibitor | 0.051 0.031 DBMET00536 | DBMET00536 | |
| 0.019 | 0.097 | 0.08 | Dopamine D5 agonist | 0.08 0.006 DBMET00536 | DBMET00536 | |
| 0.029 | 0.106 | 0.098 | Neuraminidase inhibitor | 0.098 0.016 DB00627 | DB00627 | |
| 0.016 | 0.094 | 0.056 | Glutamate (mGluR group II) agonist | 0.056 0.014 DB00627 | DB00627 | |
| 0.091 | 0.17 | 0.137 | Angiogenesis stimulant | 0.137 0.131 DBMET00536 | DBMET00536 | |
| 0.024 | 0.104 | 0.12 | Prostaglandin EP2 antagonist | 0.12 0.014 DB00627 | DB00627 | |
| 0.013 | 0.093 | 0.049 | Glutamate (mGluR2) agonist | 0.049 0.014 DB00627 | DB00627 | |
| 0.026 | 0.108 | 0.055 | CC chemokine 4 receptor antagonist | 0.055 0.021 DBMET00536 | DBMET00536 | |
| 0.005 | 0.086 | 0.051 | Prostaglandin EP1 antagonist | 0.051 0.006 DB00627 | DB00627 | |
| 0.012 | 0.095 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.008 DBMET00536 | DBMET00536 | |
| 0.002 | 0.087 | 0.009 | Progesterone receptor A antagonist | 0.009 0.008 DBMET00536 | DBMET00536 | |
| 0.001 | 0.087 | 0.011 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET00536 0.011 0.004 DB00627 | DB00627 | |
| 0.009 | 0.095 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.011 DBMET00536 | DBMET00536 | |
| 0.011 | 0.097 | 0.026 | Carnitine palmitoyltransferase 1A inhibitor | 0.026 0.025 DB00627 | DB00627 | |
| 0.024 | 0.111 | 0.053 | Thymidine kinase inhibitor | 0.053 0.017 DBMET00536 | DBMET00536 | |
| 0.027 | 0.114 | 0.073 | HIV-1 integrase (Strand Transfer) inhibitor | 0.073 0.034 DB00627 | DB00627 | |
| 0.033 | 0.121 | 0.056 | Bombesin 3 receptor antagonist | 0.056 0.038 DB00627 | DB00627 | |
| 0.015 | 0.104 | 0.037 | Estradiol 17 beta-dehydrogenase inhibitor | 0.037 0.034 DBMET00536 | DBMET00536 | |
| 0.023 | 0.113 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.032 DBMET00536 | DBMET00536 | |
| 0.004 | 0.094 | 0.036 | Kainate receptor 1 antagonist | 0.036 0.008 DB00627 | DB00627 | |
| 0.044 | 0.134 | 0.082 | Androgen antagonist | 0.082 0.064 DBMET00536 | DBMET00536 | |
| 0.018 | 0.109 | 0.039 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.035 DBMET00536 0.039 0.035 DB00627 | DB00627 | |
| 0.089 | 0.181 | 0.15 | Protein kinase (CK1) gamma 3 inhibitor | 0.15 0.089 DB00627 | DB00627 | |
| 0.035 | 0.127 | 0.075 | Glucosylceramidase inhibitor | 0.075 0.019 DBMET00536 | DBMET00536 | |
| 0.036 | 0.129 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET00536 | DBMET00536 | |
| 0.01 | 0.104 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 DBMET00536 | DBMET00536 | |
| 0.007 | 0.102 | 0.02 | Kainate receptor 3 antagonist | 0.02 0.009 DB00627 | DB00627 | |
| 0.009 | 0.104 | 0.04 | AMPA 3 receptor antagonist | 0.04 0.014 DB00627 | DB00627 | |
| 0.015 | 0.111 | 0.03 | Thymidine phosphorylase inhibitor | 0.03 0.012 DBMET00536 | DBMET00536 | |
| 0.071 | 0.167 | 0.108 | Folate antagonist | 0.108 0.052 DB00627 | DB00627 | |
| 0.042 | 0.14 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DBMET00536 | DBMET00536 | |
| 0.034 | 0.133 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 DBMET00536 | DBMET00536 | |
| 0.069 | 0.167 | 0.144 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.144 0.082 DB00627 | DB00627 | |
| 0.029 | 0.129 | 0.076 | Androgen agonist | 0.076 0.026 DBMET00536 | DBMET00536 | |
| 0.013 | 0.114 | 0.031 | Peptide deformylase inhibitor | 0.031 0.02 DBMET00536 | DBMET00536 | |
| 0.012 | 0.114 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET00536 | DBMET00536 | |
| 0.089 | 0.198 | 0.207 | Insulin secretagoues | 0.207 0.033 DB00627 | DB00627 | |
| 0.018 | 0.129 | 0.053 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET00536 0.047 0.032 DB00627 | DBMET00536 | |
| 0.014 | 0.125 | 0.035 | NMDA receptor subunit 3A antagonist | 0.035 0.03 DBMET00536 | DBMET00536 | |
| 0.033 | 0.146 | 0.066 | Factor III inhibitor | 0.048 0.041 DBMET00536 0.066 0.013 DB00627 | DB00627 | |
| 0.015 | 0.129 | 0.041 | Estrogen-related receptor gamma antagonist | 0.041 0.005 DBMET00536 | DBMET00536 | |
| 0.047 | 0.164 | 0.088 | Pim-1 kinase inhibitor | 0.088 0.07 DB00627 | DB00627 | |
| 0.013 | 0.131 | 0.043 | Lysophosphatidic acid 2 receptor antagonist | 0.043 0.011 DBMET00536 | DBMET00536 | |
| 0.029 | 0.147 | 0.069 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.039 DB00627 | DB00627 | |
| 0.09 | 0.211 | 0.168 | Dual specificity phosphatase inhibitor | 0.168 0.076 DB00627 | DB00627 | |
| 0.006 | 0.128 | 0.046 | Somatostatin 5 antagonist | 0.046 0.015 DB00627 | DB00627 | |
| 0.018 | 0.144 | 0.045 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET00536 0.039 0.036 DB00627 | DBMET00536 | |
| 0.04 | 0.168 | 0.087 | HIV-1 integrase inhibitor | 0.087 0.033 DB00627 | DB00627 | |
| 0.028 | 0.156 | 0.081 | Sphingosine kinase 2 inhibitor | 0.081 0.014 DBMET00536 | DBMET00536 | |
| 0.017 | 0.146 | 0.159 | Prostaglandin E2 antagonist | 0.159 0.008 DB00627 | DB00627 | |
| 0.061 | 0.191 | 0.095 | CC chemokine 5 receptor agonist | 0.095 0.028 DBMET00536 | DBMET00536 | |
| 0.023 | 0.155 | 0.061 | 5 Hydroxytryptamine 2A agonist | 0.061 0.046 DBMET00536 | DBMET00536 | |
| 0.048 | 0.182 | 0.097 | Vanilloid 4 agonist | 0.097 0.019 DBMET00536 | DBMET00536 | |
| 0.076 | 0.21 | 0.192 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.192 0.083 DB00627 | DB00627 | |
| 0.023 | 0.16 | 0.07 | Peroxisome proliferator-activated receptor gamma agonist | 0.07 0.049 DB00627 | DB00627 | |
| 0.018 | 0.155 | 0.048 | AMPA 4 receptor antagonist | 0.042 0.023 DBMET00536 0.048 0.016 DB00627 | DB00627 | |
| 0.071 | 0.209 | 0.175 | Protein-tyrosine phosphatase inhibitor | 0.175 0.059 DB00627 | DB00627 | |
| 0.059 | 0.198 | 0.118 | M17 leucyl aminopeptidase inhibitor | 0.118 0.079 DB00627 | DB00627 | |
| 0.021 | 0.162 | 0.036 | Adenosine uptake inhibitor | 0.036 0.021 DBMET00536 | DBMET00536 | |
| 0.047 | 0.189 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.058 DBMET00536 | DBMET00536 | |
| 0.041 | 0.185 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.032 DBMET00536 | DBMET00536 | |
| 0.069 | 0.215 | 0.116 | Protein kinase (CK1) gamma 1 inhibitor | 0.116 0.103 DB00627 | DB00627 | |
| 0.011 | 0.163 | 0.025 | Thyroid hormone agonist | 0.025 0.02 DBMET00536 | DBMET00536 | |
| 0.058 | 0.21 | 0.176 | Thrombolytic | 0.176 0.064 DB00627 | DB00627 | |
| 0.034 | 0.19 | 0.111 | Potassium channel (Ca-activated) activator | 0.111 0.047 DBMET00536 0.109 0.048 DB00627 | DBMET00536 | |
| 0.043 | 0.204 | 0.121 | Topoisomerase II inhibitor | 0.121 0.066 DB00627 | DB00627 | |
| 0.031 | 0.197 | 0.07 | DNA helicase inhibitor | 0.07 0.017 DBMET00536 0.052 0.045 DB00627 | DBMET00536 | |
| 0.136 | 0.306 | 0.223 | Toll-Like receptor 7 agonist | 0.223 0.174 DB00627 | DB00627 | |
| 0.02 | 0.192 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 DBMET00536 0.048 0.033 DB00627 | DBMET00536 | |
| 0.034 | 0.207 | 0.108 | Protein-tyrosine phosphatase 1B inhibitor | 0.108 0.071 DB00627 | DB00627 | |
| 0.133 | 0.31 | 0.219 | Toll-Like receptor agonist | 0.219 0.18 DB00627 | DB00627 | |
| 0.017 | 0.198 | 0.043 | Nicotinic acid receptor 1 agonist | 0.043 0.025 DB00627 | DB00627 | |
| 0.013 | 0.195 | 0.116 | Prostaglandin antagonist | 0.116 0.014 DB00627 | DB00627 | |
| 0.012 | 0.196 | 0.064 | NMDA 2C receptor antagonist | 0.064 0.04 DBMET00536 0.057 0.05 DB00627 | DBMET00536 | |
| 0.057 | 0.241 | 0.106 | Electron transport complex I inhibitor | 0.106 0.07 DBMET00536 | DBMET00536 | |
| 0.068 | 0.255 | 0.12 | Farnesoid X receptor antagonist | 0.12 0.103 DB00627 | DB00627 | |
| 0.028 | 0.215 | 0.075 | NMDA receptor antagonist | 0.075 0.072 DB00627 | DB00627 | |
| 0.026 | 0.222 | 0.093 | Prostaglandin F2 alpha antagonist | 0.093 0.014 DB00627 | DB00627 | |
| 0.047 | 0.248 | 0.139 | Adenylate cyclase inhibitor | 0.139 0.053 DBMET00536 | DBMET00536 | |
| 0.018 | 0.226 | 0.044 | Glutamate (mGluR8) antagonist | 0.038 0.02 DBMET00536 0.044 0.013 DB00627 | DB00627 | |
| 0.021 | 0.24 | 0.07 | Sphingosine kinase inhibitor | 0.07 0.025 DBMET00536 | DBMET00536 | |
| 0.051 | 0.271 | 0.173 | Mcl-1 antagonist | 0.173 0.072 DB00627 | DB00627 | |
| 0.034 | 0.257 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.092 0.052 DBMET00536 | DBMET00536 | |
| 0.022 | 0.274 | 0.06 | Autotaxin inhibitor | 0.06 0.029 DB00627 | DB00627 | |
| 0.083 | 0.34 | 0.145 | MAP kinase kinase 4 inhibitor | 0.145 0.072 DB00627 | DB00627 | |
| 0.012 | 0.286 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.022 DBMET00536 | DBMET00536 | |
| 0.004 | 0.281 | 0.03 | Kainate receptor 5 antagonist | 0.03 0.009 DB00627 | DB00627 | |
| 0.013 | 0.304 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.054 0.019 DB00627 | DB00627 | |
| 0.044 | 0.38 | 0.094 | Hematopoietic | 0.094 0.043 DB00627 | DB00627 | |
| 0.097 | 0.453 | 0.231 | Peptidyltransferase inhibitor | 0.231 0.066 DBMET00536 0.189 0.113 DB00627 | DBMET00536 | |
| 0.062 | 0.482 | 0.209 | Antiobesity | 0.209 0.198 DB00627 | DB00627 | |
| 0.05 | 0.821 | 0.251 | Interleukin 2 agonist | 0.251 0.117 DBMET00536 | DBMET00536 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |